Ensol Biosciences Inc. (XKON:140610)
15,350
+650 (4.42%)
At close: Oct 27, 2025
4.42% (1Y)
| Market Cap | 204.73B |
| Revenue (ttm) | 537.46M |
| Net Income (ttm) | -5.40B |
| Shares Out | 13.34M |
| EPS (ttm) | -644.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,298 |
| Average Volume | 16,983 |
| Open | 14,750 |
| Previous Close | 14,700 |
| Day's Range | 14,690 - 15,790 |
| 52-Week Range | 9,390 - 38,800 |
| Beta | 0.79 |
| RSI | 53.68 |
| Earnings Date | n/a |